Ozempic and Mounjaro are brand names of the ‘GLP-1 receptor agonist’ class of medicines, which help one manage diabetes and obesity by targeting appetite and enhancing satiety, resulting in a significant weight loss and cardiovascular benefits.
News
Sale of fake obesity drugs driven by high prices, weight-loss desire prompts health concern: Lancet
March 17, 2026Ozempic and Mounjaro are brand names of the ‘GLP-1 receptor agonist’ class of medicines, which help one manage diabetes and obesity by targeting appetite and enhancing satiety, resulting in a significant weight loss and cardiovascular benefits.